ALLcrimesfood&drugstaxestelecomcommercehealthconservationtransportationagricultureveteransbrowse all titles »
0

42 U.S.C. § 285b–8Congenital heart disease

submitted 82 years ago by Pub. L. 111-148 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 164 words · no verdicts yet

in plain englishAI-generated · not legal advice

The Institute's Director may expand and coordinate research on congenital heart disease, covering its causes, long-term outcomes, diagnosis, treatment, prevention, and barriers to lifelong care. The Director may also coordinate this research across institutions and build research networks. This work must consider how it applies to minority and medically underserved communities.

(a) In general. The Director may expand, intensify, and coordinate the Institute's research on congenital heart disease, which may cover: (1) its causes, including genetic causes; (2) long-term outcomes for people with congenital heart disease, from infants to elderly adults; (3) diagnosis, treatment, and prevention; (4) studies using data collected over time, and looking back at past data, to find effective treatments and outcomes; and (5) identifying barriers to getting lifelong care. (b) Coordination of research activities. The Director may coordinate congenital heart disease research across multiple institutions and may build research networks. (c) Minority and medically underserved communities. In doing this work, the Director must consider how it applies to minority and medically underserved communities.
the actual law source: uscode.house.gov ↗public domain
(a) In general

The Director of the Institute may expand, intensify, and coordinate research and related activities of the Institute with respect to congenital heart disease, which may include congenital heart disease research with respect to—

(1)

causation of congenital heart disease, including genetic causes;

(2)

long-term outcomes in individuals with congenital heart disease, including infants, children, teenagers, adults, and elderly individuals;

(3)

diagnosis, treatment, and prevention;

(4)

studies using longitudinal data and retrospective analysis to identify effective treatments and outcomes for individuals with congenital heart disease; and

(5)

identifying barriers to life-long care for individuals with congenital heart disease.

(b) Coordination of research activities

The Director of the Institute may coordinate research efforts related to congenital heart disease among multiple research institutions and may develop research networks.

(c) Minority and medically underserved communities

In carrying out the activities described in this section, the Director of the Institute shall consider the application of such research and other activities to minority and medically underserved communities.

Source credit: (July 1, 1944, ch. 373, title IV, § 425, as added Pub. L. 111–148, title X, § 10411(b)(2), Mar. 23, 2010, 124 Stat. 989.)

history & why it existsrecord from the source credit
  • 1944Enacted · Pub. L. 111-148 · 124 Stat. 989

A history note hasn’t been published yet. The record shows enactment by Pub. L. 111-148 on 1944-07-01.

all 0 arguments · sorted by: best

0/280

no arguments yet — make the first case